153 related articles for article (PubMed ID: 10763454)
1. Apomorphine (TAP holdings). 6a beta-aporphine-10,11-diol hydrochloride hemihydrate, apomorphine hydrochloride, spontane, Uprima.
Drugs R D; 1999 Dec; 2(6):415-6. PubMed ID: 10763454
[No Abstract] [Full Text] [Related]
2. Safety and tolerability of apomorphine SL (Uprima).
Bukofzer S; Livesey N
Int J Impot Res; 2001 Aug; 13 Suppl 3():S40-4. PubMed ID: 11477491
[TBL] [Abstract][Full Text] [Related]
3. Apomorphine SL (Uprima): a new treatment for the management of erectile dysfunction.
Wagner G
Int J Impot Res; 2001 Aug; 13 Suppl 3():S1-2. PubMed ID: 11477485
[No Abstract] [Full Text] [Related]
4. Intranasal apomorphine. Nastech Pharmaceutical.
Kendirci M; Hellstrom WJ
IDrugs; 2004 May; 7(5):483-8. PubMed ID: 15154111
[TBL] [Abstract][Full Text] [Related]
5. Apomorphine: an update of clinical trial results.
Heaton JP
Int J Impot Res; 2000 Oct; 12 Suppl 4():S67-73. PubMed ID: 11035390
[TBL] [Abstract][Full Text] [Related]
6. Future directions in erectile dysfunction therapy.
Mulhall JP
Postgrad Med; 2000 May; 107(6 Suppl Educational):19-23. PubMed ID: 19667519
[TBL] [Abstract][Full Text] [Related]
7. Apomorphine to Uprima: the development of a practical erectogenic drug: a personal perspective.
Morales A
Int J Impot Res; 2001 Aug; 13 Suppl 3():S29-34. PubMed ID: 11477489
[TBL] [Abstract][Full Text] [Related]
8. Characterising the benefit of apomorphine SL (Uprima) as an optimised treatment for representative populations with erectile dysfunction.
Heaton JP
Int J Impot Res; 2001 Aug; 13 Suppl 3():S35-9. PubMed ID: 11477490
[TBL] [Abstract][Full Text] [Related]
9. Sublingual apomorphine: new preparation. In erectile disorders: a narrow therapeutic margin.
Prescrire Int; 2002 Jun; 11(59):76-9. PubMed ID: 12068841
[TBL] [Abstract][Full Text] [Related]
10. [Apomorphine and erectile dysfunction].
Tan DQ; Yao Y; Zhang J
Zhonghua Nan Ke Xue; 2007 Sep; 13(9):818-21. PubMed ID: 17929561
[TBL] [Abstract][Full Text] [Related]
11. Oral treatment of erectile dysfunction with apomorphine SL.
Altwein JE; Keuler FU
Urol Int; 2001; 67(4):257-63. PubMed ID: 11741126
[TBL] [Abstract][Full Text] [Related]
12. An open-label, uncontrolled dose-optimization study of sublingual apomorphine in erectile dysfunction.
Mulhall JP; Bukofzer S; Edmonds AL; George M;
Clin Ther; 2001 Aug; 23(8):1260-71. PubMed ID: 11558862
[TBL] [Abstract][Full Text] [Related]
13. [Hypertension and impotence. Which potency drug is the most appropriate here?].
Köhn FM
MMW Fortschr Med; 2002 Mar; 144(10):12-3. PubMed ID: 11928255
[No Abstract] [Full Text] [Related]
14. Clinical efficacy of Apomorphine SL in erectile dysfunction of diabetic men.
Gontero P; D'Antonio R; Pretti G; Fontana F; Panella M; Kocjancic E; Allochis G; Frea B
Int J Impot Res; 2005; 17(1):80-5. PubMed ID: 15510184
[TBL] [Abstract][Full Text] [Related]
15. Tolerability and safety of apomorphine SL (Ixense (TM) ).
Montorsi F
Int J Impot Res; 2003 Apr; 15 Suppl 2():S7-9. PubMed ID: 12825097
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of apomorphine HCl].
Nagai A; Kumon H
Nihon Rinsho; 2002 Jun; 60 Suppl 6():457-60. PubMed ID: 12166200
[No Abstract] [Full Text] [Related]
17. Sublingual apomorphine for the treatment of erectile dysfunction.
Mulhall JP
Expert Opin Investig Drugs; 2002 Feb; 11(2):295-302. PubMed ID: 11829718
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of apomorphine SL in erectile dysfunction.
Mirone VG; Stief CG
BJU Int; 2001 Oct; 88 Suppl 3():25-9. PubMed ID: 11578276
[No Abstract] [Full Text] [Related]
19. The role of apomorphine SL in the treatment of male erectile dysfunction.
Heaton JP; Altwein JE
BJU Int; 2001 Oct; 88 Suppl 3():36-8. PubMed ID: 11578278
[No Abstract] [Full Text] [Related]
20. Evaluating dose regimens of apomorphine, an open-label study.
Kongkanand A; Opanuraks J; Tantiwongse K; Choeypunt N; Tantiwong A; Amornvejsukit T
Int J Impot Res; 2003 Apr; 15 Suppl 2():S10-2. PubMed ID: 12825098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]